124 related articles for article (PubMed ID: 11897121)
1. The COX inhibitors indomethacin and meloxicam exhibit anti-emetic activity against cisplatin-induced emesis in piglets.
Girod V; Dapzol J; Bouvier M; Grélot L
Neuropharmacology; 2002 Mar; 42(3):428-36. PubMed ID: 11897121
[TBL] [Abstract][Full Text] [Related]
2. Characterization of lipopolysaccharide-induced emesis in conscious piglets: effects of cervical vagotomy, cyclooxygenase inhibitors and a 5-HT(3) receptor antagonist.
Girod V; Bouvier M; Grélot L
Neuropharmacology; 2000 Sep; 39(12):2329-35. PubMed ID: 10974316
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of cyclo-oxygenase inhibitors with different isoform selectivity in lipopolysaccharide-induced preterm birth in mice.
Lee PR; Kim SR; Jung BK; Kim KR; Chung JY; Won HS; Kim A
Am J Obstet Gynecol; 2003 Jul; 189(1):261-6. PubMed ID: 12861172
[TBL] [Abstract][Full Text] [Related]
4. New cyclooxygenase-2 inhibitors for treatment of experimental autoimmune neuritis.
Miyamoto K; Oka N; Kawasaki T; Miyake S; Yamamura T; Akiguchi I
Muscle Nerve; 2002 Feb; 25(2):280-2. PubMed ID: 11870698
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of both the acute and delayed emetic responses to cisplatin in piglets treated with GR205171, a novel highly selective tachykinin NK1 receptor antagonist.
Grélot L; Dapzol J; Estève E; Frugière A; Bianchi AL; Sheldrick RL; Gardner CJ; Ward P
Br J Pharmacol; 1998 Aug; 124(8):1643-50. PubMed ID: 9756379
[TBL] [Abstract][Full Text] [Related]
7. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
8. [The renal protective effect of selective cyclooxygenase-2 inhibitor on obstructive nephropathy].
Zuo Y; Ma J; Gu Y; Yang H; Lin S
Zhonghua Nei Ke Za Zhi; 2002 Dec; 41(12):825-8. PubMed ID: 12654237
[TBL] [Abstract][Full Text] [Related]
9. Repeated administration of the 5-HT3 receptor antagonist granisetron reduces the incidence of delayed cisplatin-induced emesis in the piglet.
Grélot L; Le Stunff H; Milano S; Blower PR; Romain D
J Pharmacol Exp Ther; 1996 Oct; 279(1):255-61. PubMed ID: 8859001
[TBL] [Abstract][Full Text] [Related]
10. Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study.
Altman R; Luciardi HL; Muntaner J; Del Rio F; Berman SG; Lopez R; Gonzalez C
Circulation; 2002 Jul; 106(2):191-5. PubMed ID: 12105157
[TBL] [Abstract][Full Text] [Related]
11. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats.
Bezerra MM; de Lima V; Alencar VB; Vieira IB; Brito GA; Ribeiro RA; Rocha FA
J Periodontol; 2000 Jun; 71(6):1009-14. PubMed ID: 10914805
[TBL] [Abstract][Full Text] [Related]
12. COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam.
Weber EW; Slappendel R; Durieux ME; Dirksen R; van der Heide H; Spruit M
Eur J Anaesthesiol; 2003 Dec; 20(12):963-6. PubMed ID: 14690098
[TBL] [Abstract][Full Text] [Related]
13. A nonpeptide vasopressin V(1a) receptor antagonist, SR 49059, does not prevent cisplatin-induced emesis in piglets.
Grélot L; Girod V; Dapzol J; Maffrand JP; Serradeil-Le Gal C
Fundam Clin Pharmacol; 2001 Jun; 15(3):189-200. PubMed ID: 11468030
[TBL] [Abstract][Full Text] [Related]
14. Action of cyclooxygenase inhibitors and a leukotriene biosynthesis inhibitor on cisplatin-induced acute and delayed emesis in the ferret.
Sam TS; Ngan MP; Riendeau D; Robichaud A; Rudd JA
J Pharmacol Sci; 2007 Feb; 103(2):189-200. PubMed ID: 17310074
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibition and cardiovascular events.
Pitt B; Pepine C; Willerson JT
Circulation; 2002 Jul; 106(2):167-9. PubMed ID: 12105151
[No Abstract] [Full Text] [Related]
17. Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model.
Hussey HJ; Tisdale MJ
Int J Cancer; 2000 Jul; 87(1):95-100. PubMed ID: 10861458
[TBL] [Abstract][Full Text] [Related]
18. Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat.
Gupta YK; Chaudhary G; Sinha K
Can J Physiol Pharmacol; 2002 Mar; 80(3):210-7. PubMed ID: 11991232
[TBL] [Abstract][Full Text] [Related]
19. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins.
Konturek PC; Brzozowski T; Konturek SJ; Taut A; Kwiecien S; Pajdo R; Sliwowski Z; Hahn EG
Digestion; 1998; 59(4):284-97. PubMed ID: 9693198
[TBL] [Abstract][Full Text] [Related]
20. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
